Literature DB >> 10805967

Reduced gut intraepithelial lymphocytes in VLA1 null mice.

E J Meharra1, M Schön, D Hassett, C Parker, W Havran, H Gardner.   

Abstract

Very late antigen 1 (VLA1) is an integrin collagen receptor that is expressed by lymphocytes in several disease states. VLA1 blockade has been shown to ameliorate gut disease in experimental graft-versus-host disease. Here we show that in the VLA1 null mouse, which is generally healthy, there is a 50% reduction in gut intraepithelial lymphocytes (IELs) despite an otherwise normal lymphocyte distribution in peripheral blood and lymphoid organs. The gammadelta to alphabeta ratios of IELs are unchanged. We also find that IL2-stimulated splenocytes from VLA1 null animals show a deficiency in adhesion to fibrillar and basement membrane collagen as well as reduced proliferation in response to collagen substratum. These results suggest that some, but not all, intraepithelial lymphocytes require VLA1 to survive or proliferate within the gut epithelium or possibly to traverse the basement membrane. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805967     DOI: 10.1006/cimm.2000.1630

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  22 in total

1.  Collagen XIII induced in vascular endothelium mediates alpha1beta1 integrin-dependent transmigration of monocytes in renal fibrosis.

Authors:  Jameel Dennis; Daniel T Meehan; Duane Delimont; Marisa Zallocchi; Greg A Perry; Stacie O'Brien; Hongmin Tu; Taina Pihlajaniemi; Dominic Cosgrove
Journal:  Am J Pathol       Date:  2010-09-23       Impact factor: 4.307

Review 2.  Diversity and function of group 1 innate lymphoid cells.

Authors:  Victor S Cortez; Marco Colonna
Journal:  Immunol Lett       Date:  2016-07-06       Impact factor: 3.685

Review 3.  Integrin function in T-cell homing to lymphoid and nonlymphoid sites: getting there and staying there.

Authors:  Christopher C Denucci; Jason S Mitchell; Yoji Shimizu
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

4.  Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.

Authors:  Victor S Cortez; Luisa Cervantes-Barragan; Michelle L Robinette; Jennifer K Bando; Yaming Wang; Theresa L Geiger; Susan Gilfillan; Anja Fuchs; Eric Vivier; Joe C Sun; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2016-05-03       Impact factor: 31.745

Review 5.  γδ T cell migration: Separating trafficking from surveillance behaviors at barrier surfaces.

Authors:  Matthew A Fischer; Natasha B Golovchenko; Karen L Edelblum
Journal:  Immunol Rev       Date:  2020-08-26       Impact factor: 12.988

6.  Expression of the alpha1beta1 integrin, VLA-1, marks a distinct subset of human CD4+ memory T cells.

Authors:  Itamar Goldstein; Shomron Ben-Horin; Jianfeng Li; Ilan Bank; Hong Jiang; Leonard Chess
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Dynamic structural changes are observed upon collagen and metal ion binding to the integrin α1 I domain.

Authors:  Paul H Weinreb; Sheng Li; Sharon X Gao; Tong Liu; R Blake Pepinsky; Justin A Caravella; Jun H Lee; Virgil L Woods
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

8.  Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer.

Authors:  Ines Macias-Perez; Corina Borza; Xiwu Chen; Xuexian Yan; Raquel Ibanez; Glenda Mernaugh; Lynn M Matrisian; Roy Zent; Ambra Pozzi
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

9.  Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury.

Authors:  Xiwu Chen; Gilbert Moeckel; Jason D Morrow; Dominic Cosgrove; Raymond C Harris; Agnes B Fogo; Roy Zent; Ambra Pozzi
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 10.  Role of beta7 integrins in intestinal lymphocyte homing and retention.

Authors:  G Gorfu; J Rivera-Nieves; K Ley
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.